BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10500195)

  • 21. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.
    Regairaz M; Zhang YW; Fu H; Agama KK; Tata N; Agrawal S; Aladjem MI; Pommier Y
    J Cell Biol; 2011 Nov; 195(5):739-49. PubMed ID: 22123861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA.
    Hann CL; Carlberg AL; Bjornsti MA
    J Biol Chem; 1998 Nov; 273(47):31519-27. PubMed ID: 9813066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
    Gupta RS; Gupta R; Eng B; Lock RB; Ross WE; Hertzberg RP; Caranfa MJ; Johnson RK
    Cancer Res; 1988 Nov; 48(22):6404-10. PubMed ID: 2846151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
    Shih SJ; Erbele T; Chen AY
    Cancer Res; 2005 Oct; 65(20):9194-9. PubMed ID: 16230379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology of camptothecin and its derivatives].
    Rivory LP; Robert J
    Bull Cancer; 1995 Apr; 82(4):265-85. PubMed ID: 10846537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin.
    Walowsky C; Fitzhugh DJ; CastaƱo IB; Ju JY; Levin NA; Christman MF
    J Biol Chem; 1999 Mar; 274(11):7302-8. PubMed ID: 10066793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SpSld3 is required for loading and maintenance of SpCdc45 on chromatin in DNA replication in fission yeast.
    Nakajima R; Masukata H
    Mol Biol Cell; 2002 May; 13(5):1462-72. PubMed ID: 12006645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.
    Levin NA; Bjornsti MA; Fink GR
    Genetics; 1993 Apr; 133(4):799-814. PubMed ID: 8385050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage.
    Adachi N; So S; Koyama H
    J Biol Chem; 2004 Sep; 279(36):37343-8. PubMed ID: 15218034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.
    Pommier Y
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):3-10. PubMed ID: 8633251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatin determinants impart camptothecin sensitivity.
    Puddu F; Salguero I; Herzog M; Geisler NJ; Costanzo V; Jackson SP
    EMBO Rep; 2017 Jun; 18(6):1000-1012. PubMed ID: 28389464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks.
    Saleh-Gohari N; Bryant HE; Schultz N; Parker KM; Cassel TN; Helleday T
    Mol Cell Biol; 2005 Aug; 25(16):7158-69. PubMed ID: 16055725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.
    Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF
    Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
    Shao RG; Cao CX; Zhang H; Kohn KW; Wold MS; Pommier Y
    EMBO J; 1999 Mar; 18(5):1397-406. PubMed ID: 10064605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA repair functions that control sensitivity to topoisomerase-targeting drugs.
    Malik M; Nitiss JL
    Eukaryot Cell; 2004 Feb; 3(1):82-90. PubMed ID: 14871939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
    J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.
    Hertzberg RP; Caranfa MJ; Hecht SM
    Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct roles for Sld3 and GINS during establishment and progression of eukaryotic DNA replication forks.
    Kanemaki M; Labib K
    EMBO J; 2006 Apr; 25(8):1753-63. PubMed ID: 16601689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicase Subunit Cdc45 Targets the Checkpoint Kinase Rad53 to Both Replication Initiation and Elongation Complexes after Fork Stalling.
    Can G; Kauerhof AC; Macak D; Zegerman P
    Mol Cell; 2019 Feb; 73(3):562-573.e3. PubMed ID: 30595439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.